Down-regulation of MIF by NFκB under hypoxia accelerated neuronal loss during stroke

Si Zhang1, Odysseus Zis1, Philip T T Ly1

  • 1Townsend Family Laboratories, Department of Psychiatry, Brain Research Center, Graduate Program in Neuroscience, The University of British Columbia, Vancouver, British Columbia, Canada;

Insights

Macrophage migration inhibitory factor (MIF) protects neurons from apoptosis during stroke. Down-regulation of MIF by NFκB signaling accelerates neuronal loss, suggesting MIF is a therapeutic target for stroke treatment.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Immunology

Background:

  • Neuronal apoptosis is a key factor in post-stroke neurological deficits.
  • Inflammation and NFκB signaling are implicated in stroke pathophysiology.
  • The role of Macrophage Migration Inhibitory Factor (MIF) in stroke is not well understood.

Purpose of the Study:

  • To investigate the role of MIF in neuronal protection during stroke.
  • To elucidate the regulatory mechanisms of MIF expression in the context of stroke.
  • To assess the therapeutic potential of MIF in stroke treatment.

Main Methods:

  • Quantitative analysis of MIF expression in mouse brain infarct areas.
  • Identification and functional analysis of NFκB response elements in the human MIF promoter.
  • In vitro studies using cell cultures to assess MIF's protective effects against oxidative stress and ischemia/reperfusion.
  • In vivo studies using MIF-knockout mice to evaluate infarct development and neuronal apoptosis during stroke.

Main Results:

  • MIF expression was significantly down-regulated in the infarct area of mouse brains.
  • NFκB signaling and hypoxia synergistically reduced MIF promoter activity.
  • MIF demonstrated neuroprotective effects by reducing caspase-3 activation and apoptosis.
  • MIF deficiency in knockout mice led to increased neuronal loss and infarct volume during stroke.

Conclusions:

  • MIF exerts a significant neuroprotective effect against stroke-induced neuronal apoptosis.
  • Down-regulation of MIF by NFκB-mediated signaling under hypoxic conditions exacerbates neuronal loss.
  • Maintaining physiological MIF levels may extend the therapeutic window for stroke treatment.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
44
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.4K
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

2.0K